Demographic data | Total (n =44) | Outcome | p | |
---|---|---|---|---|
Discharged (n = 27) | Deceased (n =17) | |||
Sex n (%) | ||||
Male | 23 (52.3%) | 13 (48.1%) | 10 (58.8%) | 0.490 |
Female | 21 (47.7%) | 14 (51.9%) | 7 (41.2%) | |
Age (months) n (%) | ||||
<12 | 33 (75.0%) | 21 (77.8%) | 12 (70.6%) | MCp=0.648 |
12–60 | 8 (18.2%) | 5 (18.5%) | 3 (17.6%) | |
>60 | 3 (6.8%) | 1 (3.7%) | 2 (11.8%) | |
PIM2 | ||||
Min.–Max. | 2.0–100.0 | 2.0–72.50 | 9.0–100.0 | 0.037* |
Mean ± SD. | 39.4 ± 26.6 | 32.0 ± 22.0 | 51.1 ± 29.6 | |
Median (IQR) | 34.0 (20–56.87) | 25.6 (18.25–55.7) | 49.0 (32–71.50) | |
LOS (weeks) | ||||
Min.–Max. | 0.14–12.0 | 1.14–12.0 | 0.14–4.0 | <0.001* |
Mean ± SD. | 2.60 ± 2.33 | 3.42 ± 2.49 | 1.31 ± 1.27 | |
Median (IQR) | 2.0 (1.07–4.0) | 3.0 (2.0–4.0) | 0.71 (0.43–2.0) | |
PELOD | ||||
Min.–Max. | 6.0–30.0 | 6.0–21.0 | 16.0–30.0 | <0.001* |
Mean ± SD. | 17.16 ± 5.87 | 13.93 ± 4.28 | 22.29 ± 4.15 | |
Median (IQR) | 17 (14.0–21.5) | 14.0 (11–16.5) | 22 (18.0–24.0) | |
Resistance | ||||
MDR | 37 (84.1%) | 26 (96.3%) | 11 (64.7%) | 0.009* |
XDR | 7 (15.9%) | 1 (3.7%) | 6 (35.3%) | |
PDR | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |